To establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for domestic active pharmaceutical ingredient production.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for domestic active pharmaceutical ingredient production., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Trade.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section HD2C6497D00C84979A7C77E4A295AEF03: 1. Short title This Act may be cited as the Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines Act of...
- Section H6193A42B33E1474898FD1F0A34B4D8F3: 2. Listing of essential generic medicines Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.) is amended by inserting after section...
- Section HB300BAF5160742659545325DCF7D91F5: 319N. Listing of essential generic medicines The Secretary, in consultation with the Commissioner of Food and Drugs, the Assistant Secretary for Preparedness...
- Section H1A8A9699DE9B4AF49D0A61A77053A899: 3. Establishment of the strategic active pharmaceutical ingredient reserve Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.), as...
- Section H8C2923268617424DA782056107C7CC07: 319N–1. Strategic active pharmaceutical ingredient reserve Not later than 90 days after the date of enactment of the Promoting Readiness and Ensuring Proper...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for domestic active pharmaceutical ingredient production., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Trade
Primary Purpose
This bill, To establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for domestic active pharmaceutical ingredient production., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
IntroducedMs. Spanberger (for herself and Mr. Bacon) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
- "the_administrator"
- → The Administrator identified in the operative section
- "secretary_of_defense"
- → Secretary of Defense
- "secretary_of_homeland_security"
- → Secretary of Homeland Security
Key Definitions
Terms defined in this bill
a drug for which a generic is approved, that is medically necessary to have available at all times because the drug is— commonly used to prevent, mitigate, or treat a common disease or condition, or used in a common procedure
a drug for which a generic is approved, that is medically necessary to have available at all times because the drug is— commonly used to prevent, mitigate, or treat a common disease or condition, or used in a common procedure
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology